Skip to main
LBPH
LBPH logo

Longboard Pharmaceuticals (LBPH) Earnings Dates & Reports

Longboard Pharmaceuticals (LBPH) Most Recent Earnings

Report DateNov 7, 2024
Period EndingQ3 2024
Est. EPS-$0.58
Actual EPS-$0.63
EarningsMiss

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Longboard Pharmaceuticals (LBPH) Earnings per Share (EPS) History

Signup for full access
Browse free

Longboard Pharmaceuticals (LBPH) Latest Earnings

The value each LBPH share was expected to gain vs. the value each share gained.

Longboard Pharmaceuticals (LBPH) reported its most recent earnings on Nov 7, 2024 for Q3 2024, posting earnings per share (EPS) of -$0.63. This exceeded analysts' expectations of -$0.58 by 8.62%, marking a Miss.

For comparison, Longboard Pharmaceuticals reported EPS of -$0.55 in the same quarter last year.

The company is expected to announce its next earnings report on 11/07/2024, with analysts projecting an EPS of $0.

Longboard Pharmaceuticals (LBPH) Earnings History

Earnings
Est. EPSActual EPSSurprise
Q3 2024Nov 7, 2024
-$0.58-$0.63+8.62%
DeckReportListen
Q2 2024Aug 1, 2024
-$0.44-$0.56+27.27%
DeckReportListen
Q1 2024May 2, 2024
-$0.52-$0.42-19.23%
DeckReportListen
Q4 2023Mar 12, 2024
-$0.60-$0.63+5.00%
DeckReportListen
Q3 2023Nov 2, 2023
-$0.70-$0.55-21.43%
DeckReportListen
View all

Longboard Pharmaceuticals (LBPH) Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Longboard Pharmaceuticals’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange
Aug 1, 2024
May 2, 2024
Mar 12, 2024
Nov 2, 2023

Longboard Pharmaceuticals (LBPH) Earnings FAQs

Longboard Pharmaceuticals (LBPH) last reported earnings on Nov 7, 2024 for Q3 2024, posting an EPS of -$0.63, which Miss the estimate of -$0.58 by 8.62%.

For Q3 2024, Longboard Pharmaceuticals (LBPH) reported an EPS of -$0.63, missing analysts' estimate of -$0.58 by 8.62%.

For Q3 2024, Longboard Pharmaceuticals (LBPH) Miss expectations with an actual EPS of -$0.63 vs. an estimated EPS of -$0.58.

Following the last earnings report on Nov 7, 2024, Longboard Pharmaceuticals (LBPH)'s stock price moved — from — to —.

The next Longboard Pharmaceuticals (LBPH) earnings call is scheduled for Nov. 7, 2024, where executives will discuss financial results and outlook.

Longboard Pharmaceuticals (LBPH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.